Helse og Sykdom
Helse Og Sykdom

Probiotics and Antibiotic-Associated Diarrhea: Prevention and Treatment

Antibiotic-associated diarrhea (AAD) affects up to 30% of patients taking antibiotics, resulting from disruption of the normal gut microbiota. Probiotics—live microorganisms that confer health benefits—have been extensively studied for preventing and treating AAD. The most evidence supports Lactobacillus rhamnosus GG and Saccharomyces boulardii.

Mechanism of Action

Probiotics help restore microbial balance by competing with pathogenic bacteria for nutrients and adhesion sites, producing antimicrobial substances (bacteriocins, hydrogen peroxide), enhancing gut barrier function, and modulating immune responses. They do not permanently colonize the gut but exert transient beneficial effects.

Clinical Evidence

Multiple meta-analyses and Cochrane reviews confirm that probiotics reduce the incidence of AAD by approximately 50% when started within 72 hours of antibiotic initiation. The number needed to treat (NNT) is approximately 10-13. Probiotics also reduce the risk of Clostridioides difficile infection (CDI), a severe complication of antibiotic use.

Dosage and Timing

Effective doses typically range from 5-20 billion CFU daily for Lactobacillus strains and 250-500 mg daily for S. boulardii. Probiotics should be started as early as possible with antibiotics and continued for at least 1-2 weeks after completing the antibiotic course. Separation by 2-3 hours from antibiotic dosing may improve survival of probiotic organisms.

Safety Considerations

Probiotics are generally safe for healthy individuals. However, critically ill, immunocompromised, or those with central venous catheters should use caution due to rare cases of bacteremia or fungemia. Product quality varies; choose strains with clinical evidence and third-party verification.

Opphavsrett © Helse og Sykdom Alle rettigheter forbeholdt